First-of-its-Kind vaccine aims to stop cancer before it starts in High-Risk individuals

This early-stage study is testing an experimental vaccine designed to potentially prevent cancer in people who carry BRCA1 or BRCA2 gene mutations, which significantly increase cancer risk. The research will enroll 44 adult participants, including both cancer survivors and healthy individuals with the mutations, to check if the vaccine is safe and can activate the immune system. The vaccine is given with a brief electrical pulse to help it work better.